RHUMBLINE ADVISERS - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 178 filers reported holding PTC THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,397,943
-44.2%
107,004
+1.3%
0.00%
-40.0%
Q2 2023$4,298,086
+85741.5%
105,682
+2.2%
0.01%
-16.7%
Q1 2023$5,007
+29.1%
103,370
+1.7%
0.01%
+20.0%
Q4 2022$3,879
-99.9%
101,634
+3.1%
0.01%
-28.6%
Q3 2022$4,951,000
+37.9%
98,619
+10.0%
0.01%
+40.0%
Q2 2022$3,590,000
+29.9%
89,619
+21.0%
0.01%
+25.0%
Q1 2022$2,764,000
-6.4%
74,083
-0.1%
0.00%0.0%
Q4 2021$2,954,000
+5.8%
74,155
-1.2%
0.00%0.0%
Q3 2021$2,792,000
-12.9%
75,041
-1.1%
0.00%0.0%
Q2 2021$3,206,000
-6.0%
75,850
+5.4%
0.00%
-20.0%
Q1 2021$3,409,000
-30.7%
71,986
-10.7%
0.01%
-28.6%
Q4 2020$4,918,000
+34.3%
80,576
+2.9%
0.01%
+16.7%
Q3 2020$3,661,000
-27.4%
78,318
-21.2%
0.01%
-25.0%
Q2 2020$5,042,000
+26.9%
99,370
+11.6%
0.01%0.0%
Q1 2020$3,973,000
-6.0%
89,054
+1.2%
0.01%
+14.3%
Q4 2019$4,225,000
+54.6%
87,963
+8.8%
0.01%
+40.0%
Q3 2019$2,733,000
-23.9%
80,822
+1.3%
0.01%
-28.6%
Q2 2019$3,589,000
+40.2%
79,765
+17.3%
0.01%
+40.0%
Q1 2019$2,560,000
+23.6%
68,003
+12.6%
0.01%0.0%
Q4 2018$2,072,000
+7.7%
60,379
+47.5%
0.01%
+25.0%
Q3 2018$1,924,000
+30.5%
40,935
-6.3%
0.00%
+33.3%
Q2 2018$1,474,000
+42.6%
43,696
+14.4%
0.00%
+50.0%
Q1 2018$1,034,000
+58.1%
38,193
-2.6%
0.00%
+100.0%
Q4 2017$654,000
-22.3%
39,196
-6.9%
0.00%
-50.0%
Q3 2017$842,000
+18.4%
42,103
+8.6%
0.00%0.0%
Q2 2017$711,000
+70.9%
38,768
-8.3%
0.00%
+100.0%
Q1 2017$416,000
-7.3%
42,293
+2.9%
0.00%0.0%
Q4 2016$449,000
-23.9%
41,120
-2.3%
0.00%
-50.0%
Q3 2016$590,000
+70.5%
42,092
-14.7%
0.00%
+100.0%
Q2 2016$346,000
+58.0%
49,335
+45.2%
0.00%0.0%
Q1 2016$219,000
-79.7%
33,987
+2.2%
0.00%
-66.7%
Q4 2015$1,077,000
+31.2%
33,247
+8.1%
0.00%0.0%
Q3 2015$821,000
-44.7%
30,762
-0.3%
0.00%
-40.0%
Q2 2015$1,485,000
-5.2%
30,858
+19.8%
0.01%0.0%
Q1 2015$1,567,000
+42.5%
25,748
+21.2%
0.01%
+66.7%
Q4 2014$1,100,000
+29.9%
21,243
+10.4%
0.00%0.0%
Q3 2014$847,000
+69.4%
19,243
+0.7%
0.00%
+200.0%
Q2 2014$500,00019,1130.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Burrage Capital Management LLC 161,083$9,831,0007.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 333,000$20,323,0005.55%
RTW INVESTMENTS, LP 4,221,836$257,659,0004.32%
GEORGE KAISER FAMILY FOUNDATION 90,011$10,766,0002.85%
SECTORAL ASSET MANAGEMENT INC 603,978$36,861,0002.60%
Redwood Investments, LLC 364,837$22,266,0001.90%
ARMISTICE CAPITAL, LLC 716,000$43,697,0001.49%
CM Management, LLC 25,000$1,526,0001.42%
Third Security, LLC 237,015$14,465,0001.32%
Sofinnova Investments, Inc. 316,478$19,315,0001.15%
View complete list of PTC THERAPEUTICS INC shareholders